Drugs / MF59-eTIV-H5N1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00620815 | Nov 2007 → Jan 2008 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-eTIV-H5N1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00620815 ↗ |
| Modality | Vaccine | “Tetravalent influenza vaccine (MF59-eTIV-H5N1)” NCT00620815 ↗ |